NOTV Inotiv, Inc.

Formerly known as Bioanalytical Systems, Inc, Inotiv, Inc. is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Visit inotivco.com for more information about the Company.  This company has other shares of common stock that are publicly traded. See the "related symbols" tab.

$19.90
As of 04/09/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/27/1999
Outstanding shares:  11,131,256
Average volume:  92,400
Market cap:   $221,511,994
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    45783Q100
ISIN:        US45783Q1004
Sedol:      BN14KP6
Valuation   (See tab for details)
PE ratio:   -61.11
PB ratio:   29.71
PS ratio:   3.39
Return on equity:   -48.62%
Net income %:   -5.54%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy